GLP-1 for Women — Done Right.

The public conversation about GLP-1 has been almost entirely about celebrities, red carpet bodies, and whether using a medication for weight loss is "cheating." That conversation has been almost entirely about appearance — and almost entirely separate from what these medications actually are, what the emerging research is showing beyond weight loss, and how a woman over 40 should think about them as part of a real longevity strategy.

GLP-1 is one of the most thoroughly studied, most clinically validated, and most genuinely impactful classes of medication to emerge in modern metabolic medicine. The SELECT trial (2023) showed a 20% reduction in major adverse cardiovascular events — even independent of weight loss. The FLOW trial (2024) demonstrated significant kidney protection. Anti-inflammatory effects. Neuroprotection research. Liver health. Craving regulation. This is not a weight loss drug. It's a metabolic strategy.

But the difference between a woman who emerges from GLP-1 stronger, leaner, and more metabolically resilient — and a woman who emerges thinner but weaker, hollow-faced, and worse off than before — is not the medication. It's the protocol around the medication. Protein. Resistance training. Hormone optimization. Lab monitoring. The 14-page guide covers all of it.